We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-14.64%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$770B
AUM Growth
+$29B
Cap. Flow
+$170B
Cap. Flow %
22.02%
Top 10 Hldgs %
15.63%
Holding
8,351
New
166
Increased
4,644
Reduced
2,362
Closed
325

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.31B
2
AAPL icon
Apple
AAPL
+$8.69B
3
AMZN icon
Amazon
AMZN
+$4.42B
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.04B
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.13B

Sector Composition

Rank Sector Weight
1 Technology 17.83%
2 Healthcare 11.56%
3 Financials 9.35%
4 Consumer Discretionary 7.77%
5 Communication Services 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNOM icon
5876
Global X Genomics & Biotechnology ETF
GNOM
$85.2M
$140K ﹤0.01%
2,862
TRVN
5877
DELISTED
Trevena, Inc.
TRVN
$140K ﹤0.01%
543
+69
+15% +$15.2K
BLCN
5878
DELISTED
Siren ETF Trust Siren NexGen Economy ETF
BLCN
$139K ﹤0.01%
5,494
+3,436
+167% +$105K
FBIO icon
5879
Fortress Biotech
FBIO
$88.7M
$139K ﹤0.01%
11,057
+696
+7% +$10.3K
SUP
5880
DELISTED
Superior Industries International
SUP
$139K ﹤0.01%
35,205
-205,091
-85% -$805K
TLIS
5881
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$139K ﹤0.01%
11,443
+1,423
+14% +$22.5K
EWGS
5882
DELISTED
iShares MSCI Germany Small-Cap ETF
EWGS
$139K ﹤0.01%
2,523
DSGR icon
5883
Distribution Solutions Group
DSGR
$1.61B
$138K ﹤0.01%
5,360
+482
+10% +$10.1K
EFNL icon
5884
iShares MSCI Finland ETF
EFNL
$248M
$138K ﹤0.01%
3,984
+1,092
+38% +$42.1K
PCSA icon
5885
Processa Pharmaceuticals
PCSA
$8.61M
$138K ﹤0.01%
+98
New +$134K
LJPC
5886
DELISTED
La Jolla Pharmaceutical Company
LJPC
$138K ﹤0.01%
43,307
-758
-2% -$2.95K
DRRX
5887
DELISTED
DURECT Corp
DRRX
$137K ﹤0.01%
28,811
+14,307
+99% +$68.3K
EMPD
5888
Empery Digital
EMPD
$79.6M
0
JHMF
5889
DELISTED
John Hancock Multifactor Financials ETF
JHMF
$137K ﹤0.01%
3,214
-1,645
-34% -$76.7K
IMUX icon
5890
Immunic
IMUX
$195M
$136K ﹤0.01%
3,924
+1,543
+65% +$98.9K
JIRE icon
5891
JPMorgan International Research Enhanced Equity ETF
JIRE
$11.4B
$136K ﹤0.01%
+2,814
New +$136K
LRFC
5892
DELISTED
Logan Ridge Finance Corp
LRFC
$136K ﹤0.01%
8,597
HZON
5893
DELISTED
Horizon Acquisition Corporation II
HZON
$136K ﹤0.01%
13,714
-52,069
-79% -$515K
PHUN icon
5894
Phunware
PHUN
$43.6M
$135K ﹤0.01%
2,508
-330
-12% -$27.6K
TTSH
5895
DELISTED
Tile Shop Holdings
TTSH
$135K ﹤0.01%
43,629
+20,744
+91% +$103K
PRDS
5896
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$135K ﹤0.01%
44,127
+41,364
+1,497% +$253K
CVT
5897
DELISTED
Cvent Holding Corp. Common Stock
CVT
$135K ﹤0.01%
29,170
+18,450
+172% +$108K
ESEA icon
5898
Euroseas
ESEA
$531M
$134K ﹤0.01%
6,857
-1,283
-16% -$27.6K
KNG icon
5899
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.47B
$134K ﹤0.01%
2,721
+400
+17% +$21K
IMDX
5900
Insight Molecular Diagnostics
IMDX
$156M
$134K ﹤0.01%
7,422
-2,386
-24% -$54.3K

Similar funds

Morgan Stanley's Q2 2022 Portfolio in Review

As of Q2 2022, Morgan Stanley held 8,351 positions worth $770B, up 3.9% from $741B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley deployed $170B of net new capital in Q2 2022, opening 166 new positions and adding to 4,644 existing holdings. Its largest new stake was Goldman Sachs Future Planet Equity ETF: 2,930,007 shares worth $84M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $3.31B trimmed.

  • Morgan Stanley's largest Q2 2022 buy was Goldman Sachs Future Planet Equity ETF: 2,930,007 shares worth $84M.
  • Morgan Stanley added most to Microsoft in Q2 2022, an estimated $9.31B increase.
  • Morgan Stanley's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.31B.
  • Morgan Stanley fully exited BP Midstream Partners LP Common Units representing Limited Partner Interests in Q2 2022, selling an estimated $156M.
  • Morgan Stanley's ten largest holdings make up 16% of its $770B portfolio in Q2 2022.
  • Morgan Stanley opened 166 new positions and closed 325 in Q2 2022.
  • Morgan Stanley's portfolio value rose 3.9% quarter-over-quarter to $770B.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.